Polar Capital Global Healthcare Trust plc ("the Company")
Legal Entity Identifier: 549300YV7J2TWLE7PV84
12 June 2018
Panmure Gordon issues research on Polar Capital Global Healthcare Trust PLC (PCGH)
The concept behind the Company's relaunch in June 2017 was to capitalise on the structural change within the global healthcare sector. As the information era progresses, rapid developments create opportunities for innovative companies disrupting the conventional pharmaceutical and healthcare business models. Industry disruptors can exceed expectations with extraordinary growth. Smaller innovative sector leaders are emerging, and a number of the major market players are absorbing changes better than their competition.
If you are a Relevant Person as defined below and have not already received a copy of the research note, please contact:
Phil Hopkins |
Jonathan Crabtree |
Michael Bateman |
For further information please contact:
John Regnier-Wilson
Investment Trust Sales & Marketing, Polar Capital
020 7227 2725
The research report has been approved in the UK by Panmure Gordon solely for the purpose of section 21 of the Financial Services and Markets Act 2000. In the UK, this report is directed at and is for distribution only to persons who (i) fall within Article 19(1) (persons who have professional experience in matters relating to investments) or Article 49(2)(a) to (d) (high net worth companies, unincorporated associations etc.) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (as amended) or (ii) are professional customers or eligible counterparties of Panmure Gordon (all such persons together being referred to as "Relevant Persons").
Panmure Gordon (UK) Limited is authorised and regulated by the Financial Conduct Authority.
If you receive the research report, your attention is drawn to the disclaimer at the end of the research report.